Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Leiomyoma × Oxytocin × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Neoplasm Metastasis 1 Myoma 1 Leiomyoma 1 Hemorrhage 1 Diabetes Insipidus 1 Blood Loss, Surgical 1 Adenomyosis 1

Interventions

ulipristal acetate 9 Leuprolide 4 Uterine Artery Embolization 3 ulipristal 2 Tranexamic Acid 2 Letrozole 2 Bupivacaine 2 ferrous sulfate 1 elagolix 1 dienogest 1 cetrorelix 1 Vitamin B 6 1 Uterine Myomectomy 1 Sodium Chloride 1 Sirolimus 1 Saline Solution 1 Rocuronium 1 Pregabalin 1 Oxytocin 1 Naproxen 1 Misoprostol 1 Mifepristone 1 Lidocaine 1 Ibuprofen 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 DMAC2L protein, human 1 Celecoxib 1 Anesthetics, Local 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03937401 2019-05-03

Oxytocin in MRI-HIFU

Turku University Hospital

Phase 4 Unknown

Leiomyoma, Adenomyosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡